[Effect of droperidol, fentanyl and talamonal on the ischemic threshold of the myocardium]
Related Experiment Videos
Abstract:
The authors studied the effects of neuroleptoanalgetics on the myocardial ischemia threshold in conscious rabbits. Droperidol and talamonal were capable of raising the myocardial tolerance to ischemia. However, the myocardial tolerance to ischemia diminished as the drug doses were raised. The narcotic analgetic phentanyl (0.1 microgram/kg) did not change the myocardial ischemia threshold. The tendency toward the lowering of the myocardial tolerance to ischemia was noted after administration of higher doses of phentanyl.
Insights
Neuroleptoanalgetics like droperidol and talamonal initially improved myocardial tolerance to ischemia in rabbits. However, higher drug doses reduced this protective effect, with fentanyl showing a dose-dependent decrease in tolerance.
Area of Science:
- Cardiovascular Pharmacology
- Anesthesiology Research
- Myocardial Ischemia Studies
Context:
- Investigating the impact of anesthetic agents on cardiac function is crucial for patient safety.
- Understanding the dose-dependent effects of neuroleptoanalgesics on myocardial tolerance is essential for clinical application.
- Conscious rabbit models provide a valuable platform for studying cardiac responses to pharmacological interventions.
Purpose:
- To evaluate the influence of neuroleptoanalgesics on the threshold of myocardial ischemia in conscious rabbits.
- To determine the dose-response relationship of droperidol, talamonal, and fentanyl concerning myocardial ischemic tolerance.
Summary:
- Droperidol and talamonal demonstrated an ability to increase myocardial tolerance to ischemia.
- This protective effect was found to diminish with increasing doses of droperidol and talamonal.
- Fentanyl at a low dose (0.1 microgram/kg) did not alter the myocardial ischemia threshold, while higher doses tended to lower it.
Impact:
- Findings suggest a narrow therapeutic window for neuroleptoanalgesics regarding myocardial protection during ischemia.
- Results highlight the importance of careful dose titration of these agents in clinical settings to avoid adverse cardiac effects.
- This research contributes to the understanding of anesthetic-induced myocardial protection and potential risks.